FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
IT
Archived
•
November 10, 2026
•
The risk appears small and data is mixed, but FDA wants patients to be aware.
Source: Ars Technica | http://feeds.arstechnica.com/arstechnica/index - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



